BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Sekhmet Ventures Announces its Launch of New Venture Capital Firm with Beauty and Wellness Focus

  Sekhmet Ventures LLC, a venture capital fund focused on beauty and wellness announced its formation

  February 12, 2019

   · 

  2 min read
• Deals

  Optimapharm acquires Swiss Denothex and becomes a leading European mid-size clinical research organization

  Optimapharm, a leading independent clinical research organization (CRO) in Europe, acquired Denothex Ltd., significantly strengthening its presence in key European markets particularly in France, Germany, Switzerland, Spain and Italy and thus broadening its customer base.

  February 12, 2019

   · 

  2 min read
• Business

  Chi-Med to Announce 2018 Final Results

  Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) will announce its final results for the year ended December 31, 2018 on Monday, March 11, 2019 at 7:00 am Greenwich Mean Time (GMT).

  February 12, 2019

   · 

  2 min read
• Business

  BerGenBio ASA: Results for the Fourth Quarter and Full Year 2018

  Important progress made in 2018: PoC for bemcentinib reported in multiple cancer indications AML/MDS and NSCLC confirmed as target indications for forward development towards registration, starting in 2019 Increasing confidence in bemcentinib safety profile with more than 250 patients dosed

  February 12, 2019

   · 

  5 min read
• Business

  Poxel Announces Fourth Quarter and Full Year 2018 Financial Update

  POXEL SA announced its cash position and revenue for the fourth quarter and the twelve months ended December 31, 2018.

  February 12, 2019

   · 

  9 min read
• Business

  NPI Positioned to Expand as the Robust American Economy Continues in 2019

  The U.S. economy is booming, which is the envy of the world President Donald J. Trump said in his State of the Union address – and Nutritional Products International is ready to help domestic and international companies take advantage of the “unprecedented economic boom” that is happening in America.

  February 12, 2019

   · 

  2 min read
• Deals

  OssDsign AB Raises 64 MSEK (6 MEUR) Through Private Placement and Initiates Preparations for Stock Exchange Listing

  OssDsign AB announced the closing of a private placement of 64 MSEK.

  February 12, 2019

   · 

  2 min read
• Walgreens Boots Alliance Releases New Corporate Social Responsibility Report

  Helped to provide life-changing vitamins and minerals to more than 160 million children and women through a CSR partnership with Vitamin Angels

  February 12, 2019

   · 

  7 min read
• Business

  DelMar Pharmaceuticals Announces Second Quarter Fiscal Year 2019 Financial Results

  Company will host a business update conference call on February 19, 2019 at 4:30 PM Eastern Time

  February 12, 2019

   · 

  9 min read
• Business

  RegeneRx’s U.S. Joint Venture Initiates Key Phase 3 Dry Eye Clinical Trial with RGN-259

  RegeneRx Biopharmaceuticals, Inc. announced that ReGenTree, LLC has executed an agreement with Ora, Inc., for initiation of ARISE-3 to study ReGenTree’s new drug, RGN-259, a sterile, preservative-free eye drop for the treatment of dry eye syndrome.

  February 12, 2019

   · 

  4 min read